Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Keith S. Manchester currently holds 16,542,651 shares of Arbutus Biopharma Corp (ABUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Keith S. Manchester has been a net seller of ABUS stock. They have purchased $0 and sold $169.6M worth of shares.
Keith S. Manchester's most recent insider trade was on Dec 17, 2025, when they sold 155,076 shares at $23.02 per share.
Keith S. Manchester serves as Executive at Arbutus Biopharma Corp (ABUS). They have executed 33 insider transactions totaling $169.6M over their tenure at the company.
Keith S. Manchester holds the position of Executive at Arbutus Biopharma Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Keith S. Manchester has shown a selling trading pattern, with $0 in total purchases and $169.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Keith S. Manchester was on Sep 28, 2023, when they sold $35.3M worth of ROIV shares. This transaction involved 3,059,368 shares at $11.55 per share.
Keith S. Manchester currently owns 16,542,651 shares of Arbutus Biopharma Corp (ABUS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Keith S. Manchester's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Keith S. Manchester has 33 Form 4 filings on record as an insider at Arbutus Biopharma Corp.
Set alerts for Keith S. Manchester and 40,000+ other insiders.